Andlauer Healthcare Group (TSE:AND – Get Free Report) will announce its earnings results after the market closes on Wednesday, July 31st. Analysts expect the company to announce earnings of C$0.43 per share for the quarter.
Andlauer Healthcare Group (TSE:AND – Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported C$0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.53 by C($0.18). Andlauer Healthcare Group had a net margin of 10.02% and a return on equity of 13.82%. The firm had revenue of C$161.14 million during the quarter, compared to analysts’ expectations of C$168.50 million.
Andlauer Healthcare Group Stock Performance
Shares of TSE AND opened at C$40.64 on Tuesday. The company has a 50-day simple moving average of C$38.81 and a 200-day simple moving average of C$40.28. The company has a debt-to-equity ratio of 26.06, a current ratio of 1.94 and a quick ratio of 1.66. The company has a market cap of C$791.67 million, a PE ratio of 26.91 and a beta of 0.69. Andlauer Healthcare Group has a 12 month low of C$36.43 and a 12 month high of C$44.76.
Andlauer Healthcare Group Dividend Announcement
Insider Buying and Selling at Andlauer Healthcare Group
In other news, Director Ronald Martin Skelton sold 1,500 shares of the firm’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of C$40.87, for a total value of C$61,309.95. 1.43% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the company. Royal Bank of Canada reduced their price target on Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating on the stock in a research note on Monday, May 6th. CIBC decreased their price target on Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating on the stock in a research note on Monday, May 6th. Scotiabank downgraded shares of Andlauer Healthcare Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 14th. Stifel Nicolaus decreased their target price on shares of Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating on the stock in a research report on Monday, May 6th. Finally, TD Securities lowered their target price on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a report on Monday, May 6th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of C$49.43.
Get Our Latest Research Report on Andlauer Healthcare Group
About Andlauer Healthcare Group
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Featured Stories
- Five stocks we like better than Andlauer Healthcare Group
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Survey: Top 175 Fittest Retirement Locations in America
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- What is a Low P/E Ratio and What Does it Tell Investors?
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.